InMed’s Senior VP, Preclinical Research and Development, Dr. Eric Hsu, attending the 2025 Alzheimer’s Association International Conference, in Toronto, Canada.
Data on InMed’s Alzheimer’s disease drug candidate INM-901 was presented in a scientific poster entitled, “Therapeutic Potential of INM-901 in Mitigating Alzheimer’s Disease Pathology: Insights from a Long-term 5xFAD Mouse Model Study”.
View the poster here.
Event details here: https://aaic.alz.org/